AI Chat Paper
Discover the SciOpen Platform and Achieve Your Research Goals with Ease.
Search articles, authors, keywords, DOl and etc.
{{expandStatus?'Exit ':''}}Advanced Search
In the present study, we focused on uncovering stable genetic alterations associated with idiopathic Parkinson's disease (IPD) in blood samples. We aimed to identify factors that connect IPD to the peripheral immune system, thereby deepening our understanding of the pathophysiology of this disease.
A gene expression microarray dataset (GSE99039) was selected from the National Center for Biotechnology Information Gene Expression Omnibus database to screen for differentially expressed genes (DEGs). Subsequent analyses included Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses. A protein–protein interaction network was then constructed to identify hub genes within these DEGs. Additionally, we used a verification dataset (GSE160299) to test the consistency of the expression level changes of the hub genes.
We identified 277 DEGs, comprising 270 downregulated genes and 7 upregulated genes. The functional enrichment results revealed a close association between IPD and changes in peripheral immune status. Five hub genes—HLA-F, HLA-E, KIR3DL2, KIR3DL1, and TYROBP—were identified, and the expression level changes remained stable in the verification set.
Our findings help to clarify the regulatory pathways that connect peripheral immunity to IPD pathogenesis. We identified five key hub genes in the blood as IPD-related factors; all five genes were also significantly altered in an independent clinical dataset.
Tan EK, Chao YX, West A, et al. Parkinson disease and the immune system—associations, mechanisms and therapeutics. Nat Rev Neurol. 2020;16:303–318. https://doi.org/10.1038/s41582-020-0344-4.
Jankovic J, Tan EK. Parkinson's disease: etiopathogenesis and treatment. J Neurol Neurosurg Psychiatry. 2020;91(8):795–808. https://doi.org/10.1136/jnnp-2019-322338.
Clough E, Barrett T, Wilhite SE, et al. NCBI GEO archive for gene expression and epigenomics data sets: 23-year update. Nucleic Acids Res. 2024;52(D1):D138-D144. https://doi.org/10.1093/nar/gkad965.
Thomas PD, Ebert D, Muruganujan A, et al. PANTHER: making genome-scale phylogenetics accessible to all. Protein Sci. 2022;31(1):8–22. https://doi.org/10.1002/pro.4218.
Kanehisa M, Furumichi M, Sato Y, et al. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 2023;51(D1):D587-D592. https://doi.org/10.1093/nar/gkac963.
Szklarczyk D, Kirsch R, Koutrouli M, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638–D646. https://doi.org/10.1093/nar/gkac1000.
Grotewold N, Albin RL. Update: protective and risk factors for Parkinson disease. Parkinsonism Relat Disorders. 2024;125:107026. https://doi.org/10.1016/j.parkreldis.2024.107026.
Pinho R, Guedes LC, Soreq L, et al. Gene expression differences in peripheral blood of Parkinson's disease patients with distinct progression profiles. PLoS One. 2016;11(6):e0157852. https://doi.org/10.1371/journal.pone.0157852.
Whittle BJ, Izuogu OG, Lowes H, et al. Early-stage idiopathic Parkinson's disease is associated with reduced circular RNA expression. NPJ Parkinsons Dis. 2024;10(1):25. https://doi.org/10.1038/s41531-024-00636-y.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
京公网安备11010802044758号